Roger Slavik

3.3k total citations
47 papers, 1.3k citations indexed

About

Roger Slavik is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Roger Slavik has authored 47 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Radiology, Nuclear Medicine and Imaging, 22 papers in Pulmonary and Respiratory Medicine and 11 papers in Oncology. Recurrent topics in Roger Slavik's work include Radiopharmaceutical Chemistry and Applications (27 papers), Prostate Cancer Treatment and Research (21 papers) and Medical Imaging Techniques and Applications (11 papers). Roger Slavik is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (27 papers), Prostate Cancer Treatment and Research (21 papers) and Medical Imaging Techniques and Applications (11 papers). Roger Slavik collaborates with scholars based in United States, Germany and Switzerland. Roger Slavik's co-authors include Johannes Czernin, Jérémie Calais, Ken Herrmann, Christine E. Mona, Wolfgang P. Fendler, Matthias Eiber, Simon M. Ametamey, Linjing Mu, Andreea D. Stuparu and Roger Schibli and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Journal of Medicinal Chemistry.

In The Last Decade

Roger Slavik

47 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger Slavik United States 22 619 506 490 218 196 47 1.3k
Mitsuyoshi Yoshimoto Japan 20 619 1.0× 313 0.6× 262 0.5× 289 1.3× 400 2.0× 69 1.4k
Boris D. Zlatopolskiy Germany 21 932 1.5× 661 1.3× 256 0.5× 165 0.8× 436 2.2× 82 1.8k
Claudio Pascali Japan 21 876 1.4× 191 0.4× 224 0.5× 282 1.3× 209 1.1× 46 1.4k
Thomas Wanek Austria 24 504 0.8× 149 0.3× 1.0k 2.1× 59 0.3× 507 2.6× 92 1.9k
Peter Vermaelen Belgium 15 337 0.5× 195 0.4× 124 0.3× 98 0.4× 130 0.7× 25 812
G. Westera Switzerland 21 844 1.4× 315 0.6× 151 0.3× 81 0.4× 340 1.7× 83 1.5k
Liya Yuan United States 19 192 0.3× 328 0.6× 168 0.3× 140 0.6× 632 3.2× 34 1.6k
Annie Ogasawara United States 22 526 0.8× 146 0.3× 358 0.7× 78 0.4× 607 3.1× 30 1.4k
Norman Koglin Germany 22 536 0.9× 128 0.3× 113 0.2× 289 1.3× 367 1.9× 59 1.4k
Simon P. Williams United States 21 667 1.1× 222 0.4× 422 0.9× 81 0.4× 406 2.1× 42 1.4k

Countries citing papers authored by Roger Slavik

Since Specialization
Citations

This map shows the geographic impact of Roger Slavik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Slavik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Slavik more than expected).

Fields of papers citing papers by Roger Slavik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger Slavik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Slavik. The network helps show where Roger Slavik may publish in the future.

Co-authorship network of co-authors of Roger Slavik

This figure shows the co-authorship network connecting the top 25 collaborators of Roger Slavik. A scholar is included among the top collaborators of Roger Slavik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger Slavik. Roger Slavik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meyer, Catherine, Andreea D. Stuparu, Katharina Lueckerath, et al.. (2023). Tandem Isotope Therapy with225Ac- and177Lu-PSMA-617 in a Murine Model of Prostate Cancer. Journal of Nuclear Medicine. 64(11). 1772–1778. 16 indexed citations
2.
Liu, Michael B., Timothy J. Davis, Elizabeth Smith, et al.. (2023). Heterogeneous cardiac sympathetic innervation gradients promote arrhythmogenesis in murine dilated cardiomyopathy. JCI Insight. 8(22). 14 indexed citations
3.
Meyer, Catherine, Vikas Prasad, Andreea D. Stuparu, et al.. (2022). Comparison of PSMA-TO-1 and PSMA-617 labeled with gallium-68, lutetium-177 and actinium-225. EJNMMI Research. 12(1). 65–65. 12 indexed citations
4.
Mona, Christine E., Matthias Benz, Tristan Grogan, et al.. (2021). Correlation of 68Ga-FAPi-46 PET Biodistribution with FAP Expression by Immunohistochemistry in Patients with Solid Cancers: Interim Analysis of a Prospective Translational Exploratory Study. Journal of Nuclear Medicine. 63(7). 1021–1026. 96 indexed citations
5.
Ferdinandus, Justin, Wolfgang P. Fendler, Jérémie Calais, et al.. (2020). Impact of 68Ga-PSMA-11 PET on the management of biochemically recurrent prostate cancer in a prospective single-arm clinical trial. European Urology Open Science. 19. e1215–e1216. 2 indexed citations
6.
Stuparu, Andreea D., Catherine Meyer, Susan Evans‐Axelsson, et al.. (2020). Targeted alpha therapy in a systemic mouse model of prostate cancer - a feasibility study. Theranostics. 10(6). 2612–2620. 19 indexed citations
7.
Stuparu, Andreea D., Joseph Capri, Catherine Meyer, et al.. (2020). Mechanisms of Resistance to Prostate-Specific Membrane Antigen–Targeted Radioligand Therapy in a Mouse Model of Prostate Cancer. Journal of Nuclear Medicine. 62(7). 989–995. 36 indexed citations
8.
Ferdinandus, Justin, Wolfgang P. Fendler, Jérémie Calais, et al.. (2020). Impact of 68 Ga-PSMA-11 PET on the Management of biochemically recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial. Nuklearmedizin - NuclearMedicine. 2 indexed citations
9.
Meyer, Catherine, Andreea D. Stuparu, Wei Liu, et al.. (2019). Therapeutic Efficacy and Dosimetry of Targeted Alpha Therapy using 225Ac-PSMA-617 in a Murine Model of Prostate Cancer. Journal of medical imaging and radiation sciences. 50(4). S93–S94. 1 indexed citations
10.
Waldmann, Christopher M., et al.. (2018). Automation of a Positron-emission Tomography (PET) Radiotracer Synthesis Protocol for Clinical Production. Journal of Visualized Experiments. 1 indexed citations
11.
Waldmann, Christopher M., et al.. (2018). Automation of a Positron-emission Tomography (PET) Radiotracer Synthesis Protocol for Clinical Production. Journal of Visualized Experiments. 7 indexed citations
12.
Evans‐Axelsson, Susan, Andreea D. Stuparu, Seval Beykan, et al.. (2018). Microscale radiosynthesis, preclinical imaging and dosimetry study of [18F]AMBF3-TATE: A potential PET tracer for clinical imaging of somatostatin receptors. Nuclear Medicine and Biology. 61. 36–44. 24 indexed citations
13.
Lückerath, Katharina, Andreea D. Stuparu, Wei Liu, et al.. (2018). Detection Threshold and Reproducibility of 68Ga-PSMA11 PET/CT in a Mouse Model of Prostate Cancer. Journal of Nuclear Medicine. 59(9). 1392–1397. 21 indexed citations
14.
Lückerath, Katharina, Wei Liu, Wolfgang P. Fendler, et al.. (2018). Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer. EJNMMI Research. 8(1). 96–96. 64 indexed citations
15.
Calais, Jérémie, Wolfgang P. Fendler, Matthias Eiber, et al.. (2017). Impact of 68Ga-PSMA-11 PET/CT on the Management of Prostate Cancer Patients with Biochemical Recurrence. Journal of Nuclear Medicine. 59(3). 434–441. 118 indexed citations
16.
Slavik, Roger, Linjing Mu, Zoran Rančić, et al.. (2017). Cannabinoid receptor type 2 (CB2) as one of the candidate genes in human carotid plaque imaging: Evaluation of the novel radiotracer [ 11 C]RS-016 targeting CB2 in atherosclerosis. Nuclear Medicine and Biology. 47. 31–43. 22 indexed citations
17.
Lütje, Susanne, Roger Slavik, Wolfgang P. Fendler, Ken Herrmann, & Matthias Eiber. (2017). PSMA ligands in prostate cancer – Probe optimization and theranostic applications. Methods. 130. 42–50. 43 indexed citations
18.
Barrio, Martin, Claudio Spick, Caius G. Radu, et al.. (2016). Human Biodistribution and Radiation Dosimetry of 18F-Clofarabine, a PET Probe Targeting the Deoxyribonucleoside Salvage Pathway. Journal of Nuclear Medicine. 58(3). 374–378. 18 indexed citations
19.
Slavik, Roger, Adrienne Müller Herde, Markus Weber, et al.. (2015). Synthesis, radiolabeling and evaluation of novel 4-oxo-quinoline derivatives as PET tracers for imaging cannabinoid type 2 receptor. European Journal of Medicinal Chemistry. 92. 554–564. 54 indexed citations
20.
Slavik, Roger, Adrienne Müller, Stefanie D. Krämer, et al.. (2014). Development and Evaluation of Novel PET Tracers for Imaging Cannabinoid Receptor Type 2 in Brain. CHIMIA International Journal for Chemistry. 68(4). 208–208. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026